Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Calm before the storm

<< Previous

Bullboard Posts

Next >>

Comment by AcynicalJedion Jun 22, 2018 11:56am

32 Views

Post# 28213403

RE:RE:RE:RE:Calm before the storm

48thHighlander wrote:

AcynicalJedi wrote:

Alba1314 wrote:

BackInAction wrote:
set to boom pretty soon boys. Buckle up and enjoy the ride.

How much longer?

clearly not today

Clearly, seemingly like the rest of us, you havent a clue where it will go in the next minute or two.......... so sit back and enjoy the "eventual" ride...Pacco...